Markets Stocks Economy Crypto Earnings Banking Energy
Home Tech Feature
Tech · Exclusive

MiniMax's low-cost AI models fuel 283% revenue surge

MiniMax's low-cost AI models fuel 283% revenue surge
Tech · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Aug 26, 2026 3 min read

Chinese artificial intelligence startup MiniMax is growing at a breakneck pace by betting on a simple pitch: powerful AI doesn't have to be expensive. According to Reuters, the company's first-half revenue jumped 283.1% to $116.6 million, fueled by rising demand for its cheaper, open-source-based models and its enterprise platform.

The numbers underscore a broader shift in China's AI market, where businesses are increasingly opting for "good enough" models that are more affordable to run and easier to customize than the massive, costly systems offered by some global rivals. MiniMax, which started as a consumer-focused chatbot maker, is now leaning heavily into selling to businesses.

Enterprise pivot pays off

MiniMax's enterprise business, which includes its Open Platform and other services, saw revenue soar 703.1% to $73.9 million in the first half. That means enterprise services now account for 63.4% of the company's total sales, a clear sign that its strategy of targeting businesses rather than just consumers is working.

The company's approach is built on open-source models, which allow businesses to download, modify, and deploy AI without paying hefty licensing fees. This contrasts with the proprietary, closed-source models offered by some Western AI leaders, which often come with higher costs and less flexibility.

For everyday investors, MiniMax's growth is a reminder that the AI boom isn't just about the biggest names. Smaller players can carve out profitable niches by offering cheaper, more adaptable solutions. It also highlights a key trend: as AI becomes more commoditized, price and customization are becoming major battlegrounds.

What it means for investors

MiniMax's rapid growth is a signal that demand for cost-effective AI is strong, not just in China but globally. Companies in this position often benefit from a "land and expand" dynamic, where initial low-cost offerings lead to larger contracts over time. However, investors should also note the risks: competition in the AI space is intense, and margins can be thin when competing on price.

The broader context is that AI spending remains a key driver of tech earnings. For example, Intuit's growth push shows how even established software firms are investing heavily in AI to attract customers. Similarly, Apple's new Macs put on-device AI at the center of the pitch, underscoring the industry-wide focus on making AI more accessible and affordable.

For investors tracking the AI sector, MiniMax's numbers are a useful data point. They suggest that the demand for AI is broadening beyond the mega-cap tech giants, with smaller, nimble players finding ways to grow quickly. This could be a positive sign for the overall tech sector, but it also means investors should be selective, as not every AI startup will achieve this level of success.

Looking ahead, the key question is whether MiniMax can sustain this growth. The company's reliance on enterprise customers is a double-edged sword: it provides recurring revenue but also means it must continuously prove its value against competitors. As the AI market matures, the ability to offer low-cost, high-quality solutions will likely remain a winning formula.

For now, MiniMax's performance is a testament to the power of a low-cost strategy in a high-stakes industry. It also serves as a reminder that in the fast-moving world of AI, the companies that win are often those that can deliver practical, affordable solutions to real-world problems.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B